HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baginsky, M. L. Articles by Brown, W. V. Search for Related Content PubMed PubMed Citation Articles by Baginsky, M. L. Articles by Brown, W. V. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 20, 548-556, Copyright © 1979 by Lipid Research, Inc.

ARTICLES

A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase

ML Baginsky and WV Brown

Lipoprotein lipase (LPL) and hepatic triglyceride lipase (H-TGL) are lipolytic activities found in postheparin plasma. A simple and precise method for the direct determination of LPL in postheparin plasma is described. Pre-incubations of this plasma (45--60 min at 26 degrees C) with sodium dodecyl sulfate (35--50 mM) in 0.2 M Tris-HCl buffer, pH 8.2, results in the inactivation of H-TGL, while leaving LPL fully active. Direct determination of H-TGL is done in a separate aliquot of the same postheparin plasma sample using previously reported assay conditons that do not measure LPL. The sodium dodecyl sulfate-resistant lipolytic activity has the characteristics of LPL as judged by a) its activation by serum and by apolipoprotein C-II; b) its inactivation (over 90%) by 0.75 M NaCl; and c) its inactivation by a specific antiserum. No sodium dodecyl sulfate-resistant activity was found in postheparin plasma from a patient with LPL deficiency (primary type I hyperlipoproteinemia). An excellent correlation of values was obtained (r = 0.99) for 30 samples assayed after sodium dodecyl sulfate treatment and after immuno-inactivation of H-TGL. The intra-assay coefficient of variation was +/- 11% and 4% before and after normalization of values, respectively.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Nohara, M.-a. Kawashiri, T. Claudel, M. Mizuno, M. Tsuchida, M. Takata, S. Katsuda, K. Miwa, A. Inazu, F. Kuipers, et al. High Frequency of a Retinoid X Receptor {gamma} Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 923 - 928. [Abstract] [Full Text] [PDF]

				Y. Park, P. G Jones, and W. S Harris Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50. [Abstract] [Full Text] [PDF]

				Y. Park and W. S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J. Lipid Res., March 1, 2003; 44(3): 455 - 463. [Abstract] [Full Text] [PDF]

				V. Pruneta, D. Autran, G. Ponsin, C. Marcais, L. Duvillard, B. Verges, F. Berthezene, and P. Moulin Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity? J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 797 - 803. [Abstract] [Full Text]

				W. Weng, N. A. Brandenburg, S. Zhong, J. Halkias, L. Wu, X.-c. Jiang, A. Tall, and J. L. Breslow ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice J. Lipid Res., June 1, 1999; 40(6): 1064 - 1070. [Abstract] [Full Text]

				S. M. Grundy, G. L. Vega, J. D. Otvos, D. L. Rainwater, and J. C. Cohen Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence J. Lipid Res., February 1, 1999; 40(2): 229 - 234. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]

				J. Paterniti Jr, W. Brown, H. Ginsberg, and K Artzt Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse Science, July 8, 1983; 221(4606): 167 - 169. [Abstract] [PDF]